Xeljanz

List of products in the National Drug Code with proprietary name xeljanz. Tofacitinib is used to treat certain types of arthritis (such as psoriatic arthritis, rheumatoid arthritis, polyarticular course juvenile idiopathic arthritis-pcJIA). It helps to decrease pain/tenderness/swelling in the joints. Tofacitinib is also used to treat a certain bowel disease (ulcerative colitis). It helps to reduce symptoms of ulcerative colitis such as diarrhea, rectal bleeding, and stomach pain.

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Labeler Name Product Type
0069-0501Xeljanz XRTofacitinibTablet, Film Coated, Extended ReleaseOralPfizer Laboratories Div Pfizer IncHuman Prescription Drug
0069-0502Xeljanz XRTofacitinibTablet, Film Coated, Extended ReleaseOralPfizer Laboratories Div Pfizer IncHuman Prescription Drug
0069-1001Xeljanz TofacitinibTablet, Film CoatedOralPfizer Laboratories Div Pfizer IncHuman Prescription Drug
0069-1002Xeljanz TofacitinibTablet, Film CoatedOralPfizer Laboratories Div Pfizer IncHuman Prescription Drug
0069-1029Xeljanz TofacitinibSolutionOralPfizer Laboratories Div Pfizer IncHuman Prescription Drug
63539-012Xeljanz TofacitinibTablet, Film CoatedOralU.s. PharmaceuticalsHuman Prescription Drug
63539-016Xeljanz TofacitinibTablet, Film CoatedOralU.s. PharmaceuticalsHuman Prescription Drug
63539-501Xeljanz XRTofacitinibTablet, Extended ReleaseOralU.s. PharmaceuticalsHuman Prescription Drug
63539-502Xeljanz XRTofacitinibTablet, Extended ReleaseOralU.s. PharmaceuticalsHuman Prescription Drug